Avalyn Pharma Inc. (AVLN)
$23.74-4.27%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- -1.13
- P/E (TTM)
- -18.40
- Short % float
- 17.41%
- Days to cover
- 8.5
- SI change
- +20.2%
- 1W
- -6.65%
- 1M
- -32.13%
- vs SPY 1W
- -6.51%
- vs SPY 1M
- -34.64%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AVLN?
- LOPJLB’s latest quantitative signal on Avalyn Pharma Inc. Common Stock (AVLN) is SELL. Signals are updated daily.
- What market regime is AVLN in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Avalyn Pharma Inc. Common Stock (AVLN) do?
- Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and…